ArticleCureus2025
Radiofrequency Ablation of Leiomyomas via a Single-Site Incision.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laparoscopic radiofrequency ablation (RFA) is a minimally-invasive technique to decrease the size of tumors using thermal energy to destroy tissue. Uterine leiomyomas are common conditions comprising benign smooth muscle tumors. Single-incision laparoscopic surgery is a modern surgical approach for allowing the removal of diseased organs through a small skin incision. We aim to demonstrate the feasibility and advantages of a single-site RFA for uterine leiomyomas, highlighting its potential to reduce operative time, minimize scarring, and improve patient recovery compared to traditional multi-port approaches. We present the case of a 46-year-old female patient who presented for scheduled RFA of a dominant 4.5 cm anterior myoma causing heavy menstrual bleeding. A uterine manipulator was introduced into the endometrial cavity. A single-site port was introduced into the abdomen and laparoscopic ultrasound was then performed revealing a 4.5 cm anterior myoma as well as a posterior myoma The anterior aspect of the fibroid was desiccated using an RFA probe set at 95°C for two minutes. The probe was then repositioned to the posterior aspect and desiccated in multiple locations until complete treatment was achieved. This case demonstrates the successful treatment of a 4.5 cm anterior uterine myoma and posterior fibroid using single-site RFA, resulting in minimal blood loss, reduced postoperative pain, and rapid recovery. The surgery was performed in a manner identical to traditional laparoscopic RFA with three ports. In addition to minimal blood loss, our single-site approach resulted in less incisional pain, less scarring, and better cosmesis. The patient was discharged on the same day and rapidly resumed her activities of daily living as assessed during her postoperative visit. Our case highlights the benefits of novelty in medicine with increased patient satisfaction regarding cosmesis. This technique has the potential to reduce costs by reducing operative time and facilitating a faster return to work for the patient. With appropriately selected patients, similar access to most myomas can be achieved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.